Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BIOMARKERS, TUMOR - BLOOD , . Treffer: 33

2018

Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Dalpiaz, O; Luef, T; Seles, M; Stotz, M; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Br J Cancer. 2017; 116(1):85-90 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157
Web of Science PubMed FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Perakis, S; Auer, M; Belic, J; Heitzer, E Advances in Circulating Tumor DNA Analysis.
Adv Clin Chem. 2017; 80(10):73-153
Web of Science PubMed FullText FullText_MUG

 

2016

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776
Web of Science PubMed FullText FullText_MUG

 

Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73
Web of Science PubMed FullText FullText_MUG

 

Hügel, R; Muendlein, A; Volbeding, L; Drexel, H; Richtig, E; Wehkamp, U; Painsi, C; Lange-Asschenfeldt, B; Hauschild, A; Egberts, F Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
Melanoma Res. 2016; 26(4):354-360
Web of Science PubMed FullText FullText_MUG

 

Ling, H; Pickard, K; Ivan, C; Isella, C; Ikuo, M; Mitter, R; Spizzo, R; Bullock, M; Braicu, C; Pileczki, V; Vincent, K; Pichler, M; Stiegelbauer, V; Hoefler, G; Almeida, MI; Hsiao, A; Zhang, X; Primrose, J; Packham, G; Liu, K; Bojja, K; Gafà, R; Xiao, L; Rossi, S; Song, JH; Vannini, I; Fanini, F; Kopetz, S; Zweidler-McKay, P; Wang, X; Ionescu, C; Irimie, A; Fabbri, M; Lanza, G; Hamilton, SR; Berindan-Neagoe, I; Medico, E; Mirnezami, A; Calin, GA; Nicoloso, MS The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut. 2016; 65(6):977-989 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204
Web of Science PubMed FullText FullText_MUG

 

Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775
Web of Science PubMed FullText FullText_MUG

 

Schwameis, R; Grimm, C; Brodowicz, T; Petru, E; Hefler-Frischmuth, K; Staudigl, C; Reinthaller, A; Heinze, G; Polterauer, S; Polterauer, M Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Sci Rep. 2016; 6(5):33757-33757 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Wien Klin Wochenschr. 2016; 128(9-10):320-328 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330
Web of Science PubMed FullText FullText_MUG

 

Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Dalpiaz, O; Pichler, M; Mrsic, E; Reitz, D; Krieger, D; Venturino, L; Bezan, A; Stojakovic, T; Pummer, K; Zigeuner, R; Hutterer, GC Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
J Clin Pathol. 2015; 68(7):547-551
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Ulz, P; Geigl, JB Circulating tumor DNA as a liquid biopsy for cancer.
Clin Chem. 2015; 61(1):112-123 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Breast. 2015; 24(5):667-672
Web of Science PubMed FullText FullText_MUG

 

Reichl, P; Fang, M; Starlinger, P; Staufer, K; Nenutil, R; Muller, P; Greplova, K; Valik, D; Dooley, S; Brostjan, C; Gruenberger, T; Shen, J; Man, K; Trauner, M; Yu, J; Gao, CF; Mikulits, W Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Int J Cancer. 2015; 137(2):385-394 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sadeghi, M; Lahdou, I; Oweira, H; Daniel, V; Terness, P; Schmidt, J; Weiss, KH; Longerich, T; Schemmer, P; Opelz, G; Mehrabi, A Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Br J Cancer. 2015; 113(5):756-762 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schwameis, R; Grimm, C; Petru, E; Natter, C; Staudigl, C; Lamm, W; Koelbl, H; Krainer, M; Brodowicz, T; Reinthaller, A; Polterauer, S The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
PLoS One. 2015; 10(8):e0133838-e0133838 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473
Web of Science PubMed FullText FullText_MUG

 

2014

Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

Lindenmann, J; Fink-Neuboeck, N; Koesslbacher, M; Pichler, M; Stojakovic, T; Roller, RE; Maier, A; Anegg, U; Smolle, J; Smolle-Juettner, FM The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
J Surg Oncol. 2014; 110(6):645-650
Web of Science PubMed FullText FullText_MUG

 

Lozanovski, VJ; Houben, P; Hinz, U; Hackert, T; Herr, I; Schemmer, P Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial.
Trials. 2014; 15(2):204-204 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159
Web of Science PubMed FullText FullText_MUG

 

2013

Longerich, T; Sommer, CM; Schemmer, P; Weiss, KH 33-year-old woman with upper abdominal pain].
Dtsch Med Wochenschr. 2013; 138(20):1059-1060 (- Case Report)
PubMed FullText FullText_MUG

 

2008

Brunner, M; Thurnher, D; Heiduschka, G; Grasl, MCh; Brostjan, C; Erovic, BM Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
J Surg Oncol. 2008; 98(7):545-550
Web of Science PubMed FullText FullText_MUG

 

© Meduni Graz Impressum